Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prefoldin subunit 6 (PFDN6) is a protein chaperone that is one of six distinct components of the prefoldin complex (hexameric complex with subunits PFDN1–6), which is widely conserved in eukaryotes and archaea[2][3][4]. As part of the prefoldin complex, PFDN6 binds newly synthesized (nascent) proteins, especially cytoskeletal components actin and tubulin, and facilitates their proper folding and assembly by transferring them to the cytosolic chaperonin (CCT or TRiC) complex[1][3][4][5]. This ATP-independent binding prevents protein misfolding and aggregation, supporting cellular protein stability and the assembly of cellular structures such as the cytoskeleton[2][3][4]. Recent research suggests that PFDN6 expression is upregulated following cell activation (including immune cell activation), and overexpression has been linked to adaptive immune responses and certain cancers, suggesting a role as a disease biomarker and modulator of proteostasis in disease contexts[1]. Loss or dysregulation of prefoldin complex components can lead to defects in protein homeostasis and is implicated in protein misfolding diseases and tumor progression[3][4][5]. Currently, PFDN6 is not considered a direct therapeutic target (e.g., not a receptor, enzyme, transporter, or transcription factor), and there are no known drugs or mechanisms of action specifically targeting this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prefoldin subunit 6 (PFDN6).